Cite
HARVARD Citation
Meenan, J. et al. (2022). Tocilizumab in the management of posttransfusion hyperhemolysis syndrome in sickle cell disease: The experience so far. Transfusion. 62 (3), pp. 546-550. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Meenan, J. et al. (2022). Tocilizumab in the management of posttransfusion hyperhemolysis syndrome in sickle cell disease: The experience so far. Transfusion. 62 (3), pp. 546-550. [Online].